Lil Wayne could be in trouble with the Feds after Business Insider snitched on him.

BI used the Freedom of Information Act to obtain information about a $8.9 million COVID loan the Small Business Administration gave Wayne’s Young Money touring company in 2021.

Lil Wayne is a big fan of marijuana. He often smokes joints on podcasts and onstage, and the word “baked” is tattooed on his forehead. In 2019, he launched a marijuana brand, and a few years before that, he told an interviewer that weed was one of the most important things in his life.

But in 2021, Lil Wayne told the government his touring company was a “drug-free workplace.” The “dangers” of drugs such as weed were communicated to employees, he said, and they were told they could be punished or be forced to go to rehab.

Eventually, Lil Wayne’s company Young Money Touring Inc. was cut a $8.9 million check by the Smalls Business Administration.

According to the report, the SBA did not thoroughly investigate the claims of Lil Wayne’s company. Last year, the inspector general of the agency said that employees had just four hours to give a complete review of the applications.

The SBA also said that the drug certification process was “fairly narrow”  and it didn’t cover “personal actions” of people such as Lil Wayne, or “any drug use outside the period from March 2020 to June 2022.”

Lil Wayne’s company received the funds under the Shuttered Venue Operators Grant program, which was designed to help struggling music venues avoid bankruptcy.

In 2023, $200 million in payments were made to A-list artists, who were already clients of NKSFB, a Los Angeles asset-management firm known for its celebrity clientele.

A spokesperson for the SBA, who declined to comment on Lil Wayne’s company, noted that some funds have already been returned because of violations of the drug-free certification.